Pfizer teams up with Alloy for antibody discovery Feb. 11, 2025 9:35 AM ET Pfizer Inc. (PFE) Stock By: Val Brickates Kennedy, SA News Editor 1 Comment Play (<1min) georgeclerk ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient in a trial suffered a liver injury potentially caused by the drug.&nbsp… ...

Pfizer is facing another setback with its weight-loss pill, danuglipron. The pharmaceutical giant stopped development of the drug after liver issues affected one patient.

Drugmaker Pfizer posted a better-than-expected fourth-quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors steadier execution and growth after large ...